BIOR - Biora Therapeutics' (BIOR) CEO Adi Mohanty on Q1 2022 Results - Earnings Call Transcript

Biora Therapeutics, Inc. (BIOR) Q1 2022 Earnings Conference Call May 10, 2022 4:30 PM ET Company Participants Chuck Padala – Managing Director, LifeSci Advisors Adi Mohanty – Chief Executive Officer Eric d’Esparbes – Chief Financial Officer Conference Call Participants Julian Harrison – BTIG Sahil Kazmi – B. Riley Securities Presentation Operator Welcome to the Biora Therapeutics First Quarter 2022 Earnings Call. During the presentation, all participants will be in a listen-only mode. Afterwards, we’ll conduct a question-and-answer session. [Operator Instructions] As a reminder, today’s conference is being recorded. I’ll now turn the call over to Chuck Padala, Managing Director with LifeSci Advisors, Biora Therapeutics Investor Relations firm. Chuck Padala Thank you, operator. Good afternoon, and welcome to Biora Therapeutics first quarter 2022 corporate update and financial results conference call. Joining me on the call are Adi Mohanty, Chief Executive Officer; and Eric d’Esparbes, Chief Financial Officer. Before I turn the

For further details see:

Biora Therapeutics' (BIOR) CEO Adi Mohanty on Q1 2022 Results - Earnings Call Transcript